References
- Van CutsemESagaertXTopalBHaustermansKPrenenHGastric cancerLancet2016388100602654266427156933
- TocchiACostaGLepreLThe role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancerJ Cancer Res Clin Oncol199812484504559750022
- LeeJCLeeSYKimCYYangDHClinical utility of tumor marker cutoff ratio and a combination scoring system of preoperative carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4 levels in gastric cancerJ Korean Surg Soc201385628328924368986
- ZhengTHZhaoJLGulengBAdvances in molecular biomarkers for gastric cancerCrit Rev Eukaryot Gene Expr201525429930526559090
- SpringerGFT and Tn, general carcinoma autoantigensScience19842244654119812066729450
- ChiaJGohGBardFShort O-GalNAc glycans: regulation and role in tumor development and clinical perspectivesBiochim Biophys Acta2016186081623163926968459
- StowellSRJuTCummingsRDProtein glycosylation in cancerAnnu Rev Pathol20151047351025621663
- MilesDWHapperfieldLCSmithPExpression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancerBr J Cancer1994706127212757981088
- PinhoSSReisCAGlycosylation in cancer: mechanisms and clinical implicationsNat Rev Cancer201515954055526289314
- SchjoldagerKTClausenHSite-specific protein O-glycosylation modulates proprotein processing – deciphering specific functions of the large polypeptide GalNAc-transferase gene familyBiochim Biophys Acta20121820122079209423022508
- KitadaSYamadaSKumaAPolypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomasBr J Cancer2013109247248123799843
- HeHShenZZhangHClinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancerBr J Cancer201411082021202924619076
- NomotoMIzumiHIseTStructural basis for the regulation of UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cellsCancer Res199959246214622210626815
- LiescheFKolblACIlmerMHutterSJeschkeUAndergassenURole of N-acetylgalactosaminyltransferase 6 in early tumorigenesis and formation of metastasisMol Med Rep20161354309431427035742
- PinhoSSCarvalhoSMarcos-PintoRGastric cancer: adding glycosylation to the equationTrends Mol Med2013191166467623932995
- ParkJHNishidateTKijimaKCritical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesisCancer Res20107072759276920215525
- TaniuchiKCernyRLTanouchiAOverexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growthOncogene201130494843485421625220
- GudaKMoinovaHHeJInactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancersProc Natl Acad Sci USA200910631129211292519617566
- BeroisNGattolliatCHBarriosEGALNT9 gene expression is a prognostic marker in neuroblastoma patientsClin Chem201359122523323136245
- BeroisNMazalDUbillosLUDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer markerJ Histochem Cytochem200654331732816260590
- FreireTBeroisNSonoraCVarangotMBarriosEOsinagaEUDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 6 (ppGalNAc-T6) mRNA as a potential new marker for detection of bone marrow-disseminated breast cancer cellsInt J Cancer200611961383138816596643
- PataniNJiangWMokbelKPrognostic utility of glycosyltransferase expression in breast cancerCancer Genomics Proteomics20085633334019287074
- Milde-LangoschKSchutzeDOliveira-FerrerLRelevance of betaGal-betaGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patientsBreast Cancer Res Treat2015151351552825975956
- KolblACHillerRAIlmerMGlycosyltransferases as marker genes for the quantitative polymerase chain reaction-based detection of circulating tumour cells from blood samples of patients with breast cancer undergoing adjuvant therapyMol Med Rep20151222933293825955084
- ShimadaHNoieTOhashiMObaKTakahashiYClinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer AssociationGastric Cancer2014171263323572188
- TarhanYEKatoTJangMMorphological changes, cadherin switching, and growth suppression in pancreatic cancer by GALNT6 knockdownNeoplasia201618526527227237318
- WagnerKWPunnooseEAJanuarioTDeath-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAILNat Med20071391070107717767167
- IchikawaSSorensonAHAustinAMAblation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expressionEndocrinology200915062543255019213845
- ParkJHKatagiriTChungSKijimaKNakamuraYPolypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectinNeoplasia201113432032621472136
- Alisson-SilvaFFreire-de-LimaLDonadioJLIncrease of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cellsPLoS One201384e6047123593224
- Freire-de-LimaLGelfenbeynKDingYInvolvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition procesProc Natl Acad Sci USA201110843176901769522006308
- MatsumotoYZhangQAkitaKTrimeric Tn antigen on syndecan 1 produced by ppGalNAc-T13 enhances cancer metastasis via a complex formation with integrin alpha5beta1 and matrix metalloproteinase 9J Biol Chem201328833242642427623814067